跳至主要内容
临床试验/NCT04041037
NCT04041037终止不适用

The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series

Integra LifeSciences Corporation1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2019年3月26日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
2
试验地点
1
主要终点
Rate of Wound Closure

研究概览

简要总结

A case series involving the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healing.

详细描述

This is a prospective case series examining the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healing. Wound healing will be evaluated at 2 weeks, 6 weeks, and 3 months. If subjects heal prior to the 3 month visit, wound healing will be documented at that visit. A maximum of ten subjects will be included in this series.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject has a clinical diagnosis of pilonidal disease.
  • Subject is being scheduled for surgical excision of pilonidal disease.
  • Subject is at least 18 years of age.
  • Subject is willing and able to adhere to protocol requirements and agrees to participate in the study program and comply with the study follow-up regimen.
  • Subject is willing to provide written informed consent.

排除标准

  • Subject has a known allergy to porcine-based materials.
  • Subject is pregnant

结局指标

主要结局

Rate of Wound Closure

时间窗: Up to 3 month visit

The study was terminated by Sponsor; no outcome measure data analyses were conducted.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Management of Pilonidal Wounds With ACell... | 临床试验